The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory Diseases

Asthma, Aspirin-Induced Clinical Trial

Official title:
The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory Diseases

Status Completed

Clinical Trial Summary

The purpose of this study is to determine the effect of aspirin desensitization on symptoms and immunologic profile of patients with aspirin-exacerbated respiratory diseases (AERD).

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01867281
Study type	Interventional
Source	Tehran University of Medical Sciences
Contact
Status	Completed
Phase	Phase 4
Start date	June 2013
Completion date	June 2014

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT01681615` - Challenge Test for Acetylsalicylic Acid Hypersensitivity	N/A
Terminated	`NCT01320072` - Diagnosis of Aspirin Hypersensitivity in Aspirin Exacerbated Respiratory Disease
Completed	`NCT02824523` - Role of Inflammatory Mediators in AERD
Active, not recruiting	`NCT03028350` - Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)	Phase 2
Completed	`NCT01597375` - Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin)	Phase 2
Recruiting	`NCT04823585` - Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab)	N/A
Recruiting	`NCT05575037` - Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease	Phase 2
Completed	`NCT03326063` - Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With Ifetroban	Phase 2